(Q33367411)

26 July 2017

title

Protective activity and immunogenicity of two recombinant anthrax vaccines for veterinary use. (English)

1 reference

26 July 2017

G Garofolo

3

0 references

Fiorella Tonello

object named as

F Tonello

2

0 references

Alessandra Carattoli

object named as

A Carattoli

5

0 references

author name string

A Fasanella

1

1 reference

26 July 2017

L Muraro

4

1 reference

26 July 2017

R Adone

6

1 reference

26 July 2017

C Montecucco

7

1 reference

26 July 2017

language of work or name

English

0 references

publication date

4 September 2008

1 reference

26 July 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

26 July 2017

volume

26

1 reference

26 July 2017

issue

45

1 reference

26 July 2017

page(s)

5684-5688

1 reference

Oral spore vaccine based on live attenuated nontoxinogenic Bacillus anthracis expressing recombinant mutant protective antigen

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.026

Bacillus anthracis virulence in Guinea pigs vaccinated with anthrax vaccine adsorbed is linked to plasmid quantities and clonality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.026

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.026

Bacillus anthracis edema toxin acts as an adjuvant for mucosal immune responses to nasally administered vaccine antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.026

Detection of anthrax vaccine virulence factors by polymerase chain reaction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.026

Molecular diversity of Bacillus anthracis in Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.026

Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.026

Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.026

Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.026

Anthrax: the disease in relation to vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.026

Production and purification of anthrax toxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.026

Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.026

Duration of protection of rabbits after vaccination with Bacillus anthracis recombinant protective antigen vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.026

In vitro correlate of immunity in an animal model of inhalational anthrax

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.026

In vitro correlate of immunity in a rabbit model of inhalational anthrax

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.026

Evidence for adjuvanticity of anthrax edema toxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.026

A dually active anthrax vaccine that confers protection against both bacilli and toxins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.026

Discovery of the anthrax toxin: the beginning of in vivo studies on pathogenic bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.026

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.026

Tyrosine-728 and glutamic acid-735 are essential for the metalloproteolytic activity of the lethal factor of Bacillus anthracis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.026

Experiences with vaccination and epidemiological investigations on an anthrax outbreak in Australia in 1997.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.026

The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.026

10.1016/J.VACCINE.2008.08.026

7 January 2021

Identifiers

DOI

1 reference

26 July 2017

1 reference